Real World Evidence Study of Statin Use in Brazil (RWE-Statins)

Hospital Israelita Albert Einstein

Status: Completed

Conditions: Hypertension; Stroke; Dyslipidemias; Diabetes Mellitus; Myocardial Infarction; Cardiovascular Diseases

Treatments: Drug: Statin

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT05285085

53194121.0.0000.0071

Details and patient eligibility

About

A cross-sectional real-world data study designed to assess the use of statins in individuals assisted within the primary care system in Brazil.

Full description

Considering the high cardiovascular risk associated to high cholesterol levels, assessing the use of statins in secondary prevention as well as primary prevention individuals in real world settings is key to enable public health policy improvements.

The aim of the present study is to assess statins use in primary and secondary prevention individuals assisted by community care workers in the primary care system in Brazil, using a free real world data collection tool (epHealth database). Evaluating factors associated with statins use as well as high dose statins use are also objectives of the study.

Enrollment: 2,133,900 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All individuals aged 18 years or older registered on the epHealth database

Exclusion criteria

• None

Trial design

2,133,900 participants in 3 patient groups

Secondary prevention

Description:

Individuals with previous myocardial infarction and/or stroke

Treatment:

Drug: Statin

Primary prevention

Description:

Individuals with hypertension, diabetes and/or dyslipidemia

Treatment:

Drug: Statin

Unknown diagnosis

Description:

Individuals without a previous myocardial infarction and/or stroke or a diagnosis of hypertension, diabetes and/or dyslipidemia

Treatment:

Drug: Statin